Polymyalgia Rheumatica
(asked on 6th February 2017) - View Source
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what the timetable is for availability on the NHS of new treatments to tackle polymyalgia rheumatica.
This question was answered on 9th February 2017
Polymyalgia rheumatica is usually treated with oral or intramuscular steroid treatment and pain relieving medication. Patients who do not respond to steroid treatments may be prescribed an immunosuppressant drug, such as methotrexate.
The availability of new treatments for the condition will be subject to such treatments having demonstrated their safety, efficacy and cost effectiveness.